VIVIMEDLAB Q4 FY26 results at a glance
VIVIMED LABS LIMITED Q4 FY26 key results metrics| Quarter | Q4 FY26 |
|---|
| Quarter ended | 31 Mar 2026 |
|---|
| Revenue | ₹12 cr |
|---|
| Revenue YoY | -53.2% |
|---|
| Operating profit | -₹152 cr |
|---|
| Operating margin | -1264.9% |
|---|
| Net profit | -₹147 cr |
|---|
| Net profit YoY | -2527.2% |
|---|
| Net profit QoQ | -788.7% |
|---|
| Net margin | -1226.0% |
|---|
| Basic EPS | ₹-17.74 |
|---|
| TTM revenue | ₹69.99 cr |
|---|
| TTM net profit | -₹176 cr |
|---|
| TTM net margin | -252.1% |
|---|
VIVIMEDLAB Q4 FY26 results: what the numbers say
VIVIMED LABS LIMITED (VIVIMEDLAB) has reported its Q4 FY26 results for the quarter ended 2026-03-31. The company posted revenue of ₹12 cr and a net profit of -₹147 cr, translating into earnings per share of ₹-17.74.
Compared with the same quarter a year earlier, revenue declined sharply by -53.2% and net profit declined sharply by -2527.2%. Profit trailing revenue growth suggests costs, interest or tax absorbed part of the topline gain.
Operating profit for the quarter stood at -₹152 cr, an operating margin of -1264.9% versus -31.1% a year ago — a contraction of 1233.8 percentage points.
VIVIMEDLAB quarter-wise results table
Net profit
-₹147 cr
-2527.2% YoY
Operating profit
-₹152 cr
-1805.9% YoY
VIVIMED LABS LIMITED (VIVIMEDLAB) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q4 FY262026-03-31 | ₹12 cr | -₹152 cr | -₹147 cr | -1264.9% | -1226.0% | ₹-17.74 | -2527.2% | -788.7% |
| Q3 FY262025-12-31 | ₹15.99 cr | -₹15.55 cr | -₹16.55 cr | -97.3% | -103.5% | ₹-2.00 | — | -126.7% |
| Q2 FY262025-09-30 | ₹20.61 cr | -₹5.86 cr | -₹7.3 cr | -28.4% | -35.4% | ₹-0.88 | — | -32.9% |
| Q1 FY262025-06-30 | ₹21.39 cr | -₹5.3 cr | -₹5.49 cr | -24.8% | -25.7% | ₹-0.66 | — | +1.9% |
| Q4 FY252025-03-31 | ₹25.61 cr | -₹7.96 cr | -₹5.6 cr | -31.1% | -21.9% | ₹-0.68 | — | — |
| TTM (last 4 quarters) | ₹69.99 cr | -₹178 cr | -₹176 cr | -255.0% | -252.1% | ₹-21.28 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
VIVIMEDLAB quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
VIVIMED LABS LIMITED quarterly income statement| Particulars | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 | Q4 FY252025-03-31 |
|---|
| Revenue / Sales | ₹12 cr | ₹15.99 cr | ₹20.61 cr | ₹21.39 cr | ₹25.61 cr |
|---|
| Total expenses | ₹164 cr | ₹31.54 cr | ₹26.47 cr | ₹26.68 cr | ₹33.58 cr |
|---|
| Gross profit | -₹34.93 cr | ₹8.09 cr | ₹11.49 cr | ₹11.59 cr | ₹14.17 cr |
|---|
| Operating profit (EBIT) | -₹152 cr | -₹15.55 cr | -₹5.86 cr | -₹5.3 cr | -₹7.96 cr |
|---|
| Operating margin | -1264.9% | -97.3% | -28.4% | -24.8% | -31.1% |
|---|
| Interest cost | ₹0.95 cr | ₹1 cr | ₹1.66 cr | ₹0.58 cr | ₹1.74 cr |
|---|
| Profit before tax | -₹147 cr | -₹16.55 cr | -₹7.3 cr | -₹5.49 cr | -₹5.49 cr |
|---|
| Tax expense | ₹0.14 cr | ₹0 cr | ₹0 cr | ₹0 cr | ₹0.11 cr |
|---|
| Effective tax rate | -0.1% | 0.0% | 0.0% | 0.0% | -2.1% |
|---|
| Net profit (PAT) | -₹147 cr | -₹16.55 cr | -₹7.3 cr | -₹5.49 cr | -₹5.6 cr |
|---|
| Net profit margin | -1226.0% | -103.5% | -35.4% | -25.7% | -21.9% |
|---|
| Basic EPS | ₹-17.74 | ₹-2.00 | ₹-0.88 | ₹-0.66 | ₹-0.68 |
|---|
| Diluted EPS | ₹-17.74 | ₹-2.00 | ₹-0.88 | ₹-0.66 | ₹-0.68 |
|---|
VIVIMEDLAB results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 |
|---|
| Revenue YoY | -53.2% | — | — | — | — |
|---|
| Revenue QoQ | -24.9% | -22.4% | -3.6% | -16.5% | — |
|---|
| Operating profit YoY | -1805.9% | — | — | — | — |
|---|
| Operating profit QoQ | -876.1% | -165.4% | -10.7% | +33.5% | — |
|---|
| Net profit YoY | -2527.2% | — | — | — | — |
|---|
| Net profit QoQ | -788.7% | -126.7% | -32.9% | +1.9% | — |
|---|
| EPS YoY | -2508.8% | — | — | — | — |
|---|
| EPS QoQ | -787.0% | -127.3% | -33.3% | +2.9% | — |
|---|
VIVIMEDLAB annual results history
Full-year performance for VIVIMED LABS LIMITED, useful for reading each quarter in context.
VIVIMED LABS LIMITED annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹69.99 cr | ₹116 cr | ₹149 cr | ₹187 cr |
|---|
| Total expenses | ₹248 cr | ₹150 cr | ₹170 cr | ₹393 cr |
|---|
| Gross profit | -₹3.76 cr | ₹56.42 cr | ₹71.6 cr | -₹92.87 cr |
|---|
| Operating profit (EBIT) | -₹178 cr | -₹33.27 cr | -₹20.64 cr | -₹206 cr |
|---|
| Operating margin | -255.0% | -28.6% | -13.8% | -109.9% |
|---|
| Interest cost | ₹4.17 cr | ₹2.95 cr | ₹1.21 cr | ₹35 cr |
|---|
| Profit before tax | -₹176 cr | -₹31.85 cr | -₹45.82 cr | -₹331 cr |
|---|
| Tax expense | ₹0.14 cr | ₹0.11 cr | -₹0.38 cr | -₹2.12 cr |
|---|
| Effective tax rate | -0.1% | -0.4% | 0.8% | 0.6% |
|---|
| Net profit (PAT) | -₹176 cr | -₹31.96 cr | -₹45.45 cr | -₹329 cr |
|---|
| Net profit margin | -252.1% | -27.5% | -30.5% | -175.6% |
|---|
| Basic EPS | — | ₹-3.85 | ₹-5.48 | ₹-39.62 |
|---|
| Diluted EPS | — | ₹-3.85 | ₹-5.48 | ₹-39.62 |
|---|
Revenue trend and demand read-through
Topline for Q4 FY26 came in at ₹12 cr against ₹25.61 cr in Q4 FY25, and ₹15.99 cr in the preceding Q3 FY26 quarter.
On a sequential basis revenue declined -24.9%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹164 cr, or 1364.9% of revenue, with operating profit declined -1805.9% year on year.
Margins, tax and profitability
Net profit of -₹147 cr works out to a net margin of -1226.0% compared with -21.9% in the year-ago quarter. Margin pressure of this kind usually reflects higher input costs, pricing competition, or a heavier interest and depreciation load.
Below the operating line, VIVIMED LABS LIMITED reported profit before tax of -₹147 cr, a tax charge of ₹0.14 cr (effective rate -0.1%), interest cost of ₹0.95 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from -₹16.55 cr in Q3 FY26 to -₹147 cr in Q4 FY26, a change of -788.7%.
Trailing twelve months and annual context
Across the trailing four quarters VIVIMED LABS LIMITED has generated revenue of ₹69.99 cr and net profit of -₹176 cr, a trailing net margin of -252.1%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹69.99 cr with net profit of -₹176 cr and EPS of —, versus the prior year where revenue declined -39.8% and profit declined -452.1%.
What to watch in the next VIVIMEDLAB quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A single weak quarter matters less than the direction over three to four consecutive quarters.
VIVIMED LABS LIMITED has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
VIVIMEDLAB results coverage
No results report published for VIVIMEDLAB yet — our desk covers each quarter within minutes of the filing.
VIVIMEDLAB quarterly results FAQs
What were VIVIMED LABS LIMITED (VIVIMEDLAB) Q4 FY26 results?
In Q4 FY26 (quarter ended 31 Mar 2026), VIVIMED LABS LIMITED reported revenue of ₹12 cr and net profit of -₹147 cr, a change of -2527.2% year on year on -53.2% revenue growth. EPS stood at ₹-17.74.
What is VIVIMEDLAB profit margin in Q4 FY26?
VIVIMED LABS LIMITED posted a net profit margin of -1226.0% and an operating margin of -1264.9% in Q4 FY26. On a trailing twelve-month basis, revenue is ₹69.99 cr and net profit -₹176 cr.
Did VIVIMEDLAB results beat the previous quarter?
VIVIMED LABS LIMITED net profit changed -788.7% quarter on quarter, from -₹16.55 cr in Q3 FY26 to -₹147 cr in Q4 FY26.
When are VIVIMED LABS LIMITED (VIVIMEDLAB) quarterly results?
VIVIMED LABS LIMITED has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see VIVIMEDLAB latest quarterly results?
Results coverage for VIVIMEDLAB will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the VIVIMEDLAB stock page.
What is VIVIMED LABS LIMITED annual revenue and profit?
For FY26, VIVIMED LABS LIMITED reported full-year revenue of ₹69.99 cr and net profit of -₹176 cr, with EPS of —.
How many quarterly results has VIVIMEDLAB declared recently?
Past results dates for VIVIMEDLAB will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
